HLI Interviews from Psychedelic Therapeutics and Drug Development Conference

 
 
 
 

We bring you six interviews with leaders in the psychedelics industry who will be presenting at the Psychedelic Therapeutics & Drug Development Conference taking place in San Francisco on May 15 & 16, 2023.  The episode spans a variety of topics, each crucial to the development of psychedelic medicines.  We begin with government funded drug discovery research, followed by a look at the clinical research landscape both in academia and industry settings.  Next our interviewees discuss legal considerations in the field of psychedelic drug development, from both regulatory and intellectual property lenses.  To close the episode out we discuss trends in the current investment landscape.  Be sure to check out the full conference agenda at psychedelics-conference.com and join us in person at the event as we continue these discussions! 

Moderators

Nigam B. Arora, PhD (moderator)

Jahan Marcu, PhD (moderator)

Guests

Ryan Gumpper, PhD - Roth lab at UNC Chapel Hill and DARPA’s Focused Pharma Initiative

Joshua D. Woolley, MD, PhD - UCSF Weill Institute for Neurosciences & Translational Psychedelic Research Program

Sabrina Ramkellawan & Jaspreet K. Grewal, MBA - AxialBridge

Kimberely Chew, JD - Husch Blackwell

Graham Pechenik, JD - Calyx Law

Tim Schlidt - Palo Santo

Credits:

Podcast audio engineering by Joe Leonardo. Intro music by Buddha by Kontekst. Transition music by K. LOUK. Outro music by Bensounds.

 
Previous
Previous

How to Launch a Community

Next
Next

20 Grams